The all-natural ingredient, which can be used in a variety of dairy formulations, is manufactured in Japan by Mitsubishi Gas Chemical and is the only pyrroloquinoline quinone available for purchase by nutraceutical companies and supplement manufacturers in Europe. It’s the same ingredient as BioPQQ, known in North America and Asia.
Clinical studies suggest the ingredient can activate mitochondrial biogenesis, meaning it can energize the mitochondria in cells. Studies also show MGCPQQ can potentially support Nerve Growth Factor, and that the ingredient may play a role in nerves and other organs growing or recovering after being damaged. Neurons are susceptible to lethal damage from oxidative stress, and neuronal death is regarded as a causal factor in some cognitive disorders.
Shoji Matsukawa, general manager, organic chemicals sales & marketing for Mitsubishi Gas Chemical America said, “The ingredient has been well-received in the US, and we are incredibly excited to be launching it in the European market. MGCPQQ has been extensively tested and has shown to help support mitochondrial activation and cognitive function.”
MGCPQQ is on the EU’s approved list of Novel Foods, and is, under the BioPQQ name, the only supplement of its kind with NDI notification from the U.S. Food and Drug Administration and GRAS status, enabling it to be used as a food ingredient.
MCLS Europe is the first distributor of MGCPQQ in the European Union.
